Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Brian Ng'andu"'
Autor:
Margareth Ndomondo-Sigonda, Jacqueline Miot, Shan Naidoo, Nelson E. Masota, Brian Ng’andu, Nancy Ngum, Eliangiringa Kaale
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Limited capacity to regulate medical products is associated with circulation of products which do not meet standards of quality, safety and efficacy with negative public health and economic outcomes. This study focused on assessin
Externí odkaz:
https://doaj.org/article/d020d1c6fad7490188760dda7b2d4713
Autor:
Margareth Ndomondo-Sigonda, Jacqueline Miot, Shan Naidoo, Brian Ng'andu, Nancy Ngum, Nelson E Masota, Eliangiringa Kaale
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0236332 (2020)
IntroductionAdequate and sustainable funding of national medicine regulatory agencies (NMRAs) is key for assurance of quality, safety and efficacy of medical products circulating in a market. The study aimed to determine factors affecting NMRAs fundi
Externí odkaz:
https://doaj.org/article/aa030a7b273c44ef932a71d78a18a9ad
Autor:
Nancy Ngum, Jacqueline Miot, Brian Ng’andu, Margareth Ndomondo-Sigonda, Eliangiringa Kaale, Shan Naidoo, Nelson E. Masota
Publikováno v:
BMC Public Health
BMC Public Health, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Public Health, Vol 21, Iss 1, Pp 1-13 (2021)
Background Limited capacity to regulate medical products is associated with circulation of products which do not meet standards of quality, safety and efficacy with negative public health and economic outcomes. This study focused on assessing the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::900ca78ae7a40c4b3f1de22c3b50e68d
https://doi.org/10.21203/rs.3.rs-35630/v4
https://doi.org/10.21203/rs.3.rs-35630/v4
Autor:
Nelson E. Masota, Eliangiringa Kaale, Brian Ng’andu, Jacqueline Miot, Nancy Ngum, Margareth Ndomondo-Sigonda, Shan Naidoo
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 7, p e0236332 (2020)
PLoS ONE, Vol 15, Iss 7, p e0236332 (2020)
IntroductionAdequate and sustainable funding of national medicine regulatory agencies (NMRAs) is key for assurance of quality, safety and efficacy of medical products circulating in a market. The study aimed to determine factors affecting NMRAs fundi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88d35f182ed3765322c933c117e3c4f2
http://europepmc.org/articles/PMC7377437
http://europepmc.org/articles/PMC7377437